SAN DIEGO, March 6 /PRNewswire-FirstCall/ -- Bridgetech Holdings International Inc. , a company focused on maximizing the potential of emerging healthcare products and services in the U.S. and Asian markets, and Wu Jieping (WJP) Medical Foundation, a non-profit organization under the Ministry of Health, announced today that they have established a new entity to distribute Bridgetech’s products throughout the Peoples Republic of China (PRC). This new entity will have first right of refusal on all of Bridgetech’s products and can not distribute any products that might compete with Bridgetech.
According to Michael Chermak, Chairman and CEO of Bridgetech, this agreement has an initial term of 10 years and could potentially include all of Bridgetech’s diagnostics and therapeutics. Chermak noted that WJP’s position as a leader in the education of medical professionals and institutions in the PRC would be a great facilitator in this process. “As the WJP Medical Foundation is the recognized leader in the dissemination of the latest and most trusted healthcare information in China, it follows that they would become a leading source of the latest diagnostics and therapeutics,” he said. “WJP wants to further improve the healthcare environment in China by ensuring that the leading facilities in China have access to these new emerging world-class products.”
The highly regarded WJP Medical Foundation works with an extensive member network of more than 300 of China’s most esteemed hospitals. “One of the four key components of our business strategy focuses on distribution,” noted Chermak. “This relationship forms a strong foundation for our distribution network. The direct access this provides us to China’s most highly regarded hospitals will significantly facilitate the expansion of our distribution network to additional facilities throughout the PRC,” said Chermak.
Dr. Fang Jun, Secretary General of WJP Medical Foundation and one of China’s most respected medical professionals, said, “We are truly pleased with this collaborative relationship. Bridgetech’s products allow us to move past education and provide our members direct access to some of the most advanced healthcare technologies available.” Dr. Fang added, “One of our goals is to assure that our member facilities have the tools necessary to apply what they have learned, and increase the quality of treatment options available to their patients.”
About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in China. The company is bringing emerging drugs, devices and diagnostics to China, with an initial focus on oncology and women’s health. Bridgetech has also established domestic operations to support its China initiatives. For additional information, please visit www.bthi.com.
About Wu Jieping Medical Foundation
In a short time, the non-profit Wu Jieping Medical Foundation (WJPF) has become one of China’s most respected and trusted sources for independent healthcare information. Founded in 2002 in Beijing, WJPF was approved by the Ministry of Health (MOH) and Ministry of Civil Affairs in China and is under the administration of MOH. It fosters health through education and academic exchange. The mission of this charitable organization is to promote and, ultimately, introduce state-of-the-art healthcare products and services to the medical community and consumers alike. To meet the ever-expanding dynamics of this market, WJPF is developing a web portal, in partnership with Bridgetech Holdings International, to unite all medical professionals in and outside China who share an interest in the development of medicine and health in China.
Forward-Looking Statements.
Statements contained in this press release that are not statements of historical fact are “forward-looking statements” as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intention or strategies for the future of Bridgetech. Forward-looking statements may be identified by words such as “goals,” “plans,” “believes,” “will,” “expects” and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place any undue reliance on any forward-looking statements.
Contacts: Media Relations: Vince Heald, Beck Ellman Heald - 858-453-9600 vheald@behmedia.com Investor Relations: Redwood Consultants, LLC - 415-884-0348
Bridgetech Holdings International Inc.
CONTACT: Media Relations, Vince Heald of Beck Ellman Heald,+1-858-453-9600, vheald@behmedia.com; or Investor Relations, RedwoodConsultants, LLC, +1-415-884-0348, both for Bridgetech HoldingsInternational Inc.
Web site: http://www.bthi.com/
